Rationale and Design of the allogeneiC Human Mesenchymal Stem Cells (hMSC) in Patients With Aging fRAilTy via intravenoUS Delivery (CRATUS) Study: A Phase I/Ii, Randomized, Blinded and Placebo Controlled Trial to Evaluate the Safety and Potential Efficacy of Allogeneic Human Mesenchymal Stem Cell Infusion in Patients With Aging Frailty
Oncotarget - United States
doi 10.18632/oncotarget.7727
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 25, 2016
Authors
Publisher
Impact Journals, LLC